Zebrafish help decode link between calcium deficiency and colon cancer

The image depicts two zebrafish. One has been raised in water containing a normal concentration of calcium and the other has been raised under low calcium conditions. The specific cells that specialize in calcium uptake for the body have been stained. It is apparent that under normal calcium conditions (top panel) there are just a few of these cells present. Under low calcium conditions (bottom panel) the staining has elucidated exponentially more of these cells (many more dark spots present).

A tiny, transparent fish embryo and a string of surprises led scientists to a deeper understanding of the perplexing link between low calcium and colon cancer.

By studying zebrafish embryo skin, University of Michigan researchers decoded cell messages underlying abnormal colonic cell growth of the kind that can lead to tumors and in calcium deficient individuals. They have also tested this new mechanism in human colon cancer .

Ultimately, the new biological mechanism unraveled in zebrafish will help scientists understand the pathways that fuel low calcium-related abnormal colonic cell growth and how to stop that growth, said Cunming Duan, professor in the U-M Department of Molecular, Cellular & Developmental Biology.

To do this, Duan and colleagues used a fluorescent protein to mark a type of epithelial cell, whose job it is to import calcium into the body. The cells behave essentially the same in people and zebrafish, but scientists can study the live cells in zebrafish embryos because they sit on the skin, instead of in the intestine and gut, as with humans.

When the researchers placed the zebrafish embryos in calcium-depleted water, they were surprised that it activated a particular that stimulates division and growth in these . The calcium transporter (TRPV5/6) must be present for this activation, which is an apparent survival mechanism for animals to import calcium into cells in low-calcium environments.

Animals and people cannot survive without enough calcium, so regulating calcium is critical, Duan said. The link of a calcium transporter to this growth factor signaling pathway is new, and scientists demonstrated the same pathway at work in human . The discovery also demonstrates the built-in, evolutionarily conserved calcium regulation mechanism that helps humans and animals survive low-calcium conditions.

Understanding the mechanisms behind the calcium-induced abnormal colonic is the first step in developing drugs or other therapies to prevent it, Duan said.

"Theoretically, it's a possibility you could someday apply this to humans and block human colon cancer cell division," he said.

Duan said several surprising findings and unlikely players converged to push the research along. First, Duan's lab doesn't even study cancer, but rather the growth factor in zebrafish embryo development.

"We found accidentally that these cells divide like crazy when you change the water level," Duan said.

After that, the research swerved in a new direction.

"We then wondered if the growth factor involved had anything to do with colon cancer," he said.

More information: The paper, "Calcium deficiency-induced and TRP channel-regulated IGF1R-PI3K-Akt signaling regulates abnormal epithelial cell proliferation," appears Dec. 13 in the journal Cell Death and Differentiation.

Related Stories

New study finds key mechanism in calcium regulation

Jan 03, 2013

All living cells keep their cellular calcium concentration at a very low level. Since a small increase in calcium can affect many critical cellular functions (an elevated calcium concentration over an extended period can ...

New target to stop cancer's spread discovered

Jan 30, 2013

Disrupting a key interaction between two types of proteins in cells inhibits the spread of cancerous cells, providing researchers with a new pathway toward developing cancer-fighting drugs, according to new findings by Georgia ...

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.